Skip to main content

ADVERTISEMENT

Kathy Drushal, RN, CCRN

Feature
06/19/2008
ABSTRACT Background.The SyvekPatch® (Marine Polymer Technologies, Danvers, MA) has received Food and Drug Association market clearance for the rapid control of bleeding from vascular access sites and percutaneous catheters. A clinical...
ABSTRACT Background.The SyvekPatch® (Marine Polymer Technologies, Danvers, MA) has received Food and Drug Association market clearance for the rapid control of bleeding from vascular access sites and percutaneous catheters. A clinical...
ABSTRACT Background.The...
06/19/2008
Cath Lab Digest
Original Contribution
08/01/2008
Management of bleeding at the femoral vascular access site following percutaneous catheterization is of paramount importance. Traditionally, manual or mechanical compression has been the standard approach to achieve hemostasis.
Management of bleeding at the femoral vascular access site following percutaneous catheterization is of paramount importance. Traditionally, manual or mechanical compression has been the standard approach to achieve hemostasis.
Management of bleeding at the...
08/01/2008
Journal of Invasive Cardiology
06/19/2008
The Miami Heart cath lab staff is continually looking for ways to improve patient care. They recently completed a study using Angiomax® (bivalirudin) and the SyvekPatch®, testing early sheath removal with this treatment combination while...
The Miami Heart cath lab staff is continually looking for ways to improve patient care. They recently completed a study using Angiomax® (bivalirudin) and the SyvekPatch®, testing early sheath removal with this treatment combination while...
The Miami Heart cath lab staff...
06/19/2008
Cath Lab Digest
06/19/2008
ABSTRACT Background.The SyvekPatch® (Marine Polymer Technologies, Danvers, MA) has received Food and Drug Association market clearance for the rapid control of bleeding from vascular access sites and percutaneous catheters. A clinical...
ABSTRACT Background.The SyvekPatch® (Marine Polymer Technologies, Danvers, MA) has received Food and Drug Association market clearance for the rapid control of bleeding from vascular access sites and percutaneous catheters. A clinical...
ABSTRACT Background.The...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
The Miami Heart cath lab staff is continually looking for ways to improve patient care. They recently completed a study using Angiomax® (bivalirudin) and the SyvekPatch®, testing early sheath removal with this treatment combination while...
The Miami Heart cath lab staff is continually looking for ways to improve patient care. They recently completed a study using Angiomax® (bivalirudin) and the SyvekPatch®, testing early sheath removal with this treatment combination while...
The Miami Heart cath lab staff...
06/19/2008
Cath Lab Digest